Hi all,
I'm getting very confused about 'myeloblasts'.
1) Pathoma classifies 'myeloblast' as the progenitor of neutrophils, basophils, and eoisonophils and 'monoblast' as the progenitor for monocytes/macrophages. However, Sattar also says/contradicts himself by saying that GM-CFU or G-CFU can be used as a treatment for neutropenia (implying that monocytes + granulocytes have a common progenitor)
2) Goljan has a chart in his book (pg 280 4e), where there is no myeloblast at all, and where GM-CFU gives off to both neutrophils AND monocytes (implying a different classification than Pathoma...see point 1)
3) Robbins (pg 591) does not have a myeloblast at all, and has a different lineage of hematopoieses than both Goljan and Pathoma!
Can anyone clarify this term for me? And especially in regards to myeloblastic leukemias / disorders? Are myeloproliferative disorders referring to the 'myeloid stem cell' or 'myeloblast' (whatever this is)? Why does AML refer to 'myeloblast' if it has subtypes involving megakaryoblasts (M7)? Shouldn't myeoblast only refer to granulocytes?
Any help is appreciated! I'm dying here.
I'm getting very confused about 'myeloblasts'.
1) Pathoma classifies 'myeloblast' as the progenitor of neutrophils, basophils, and eoisonophils and 'monoblast' as the progenitor for monocytes/macrophages. However, Sattar also says/contradicts himself by saying that GM-CFU or G-CFU can be used as a treatment for neutropenia (implying that monocytes + granulocytes have a common progenitor)
2) Goljan has a chart in his book (pg 280 4e), where there is no myeloblast at all, and where GM-CFU gives off to both neutrophils AND monocytes (implying a different classification than Pathoma...see point 1)
3) Robbins (pg 591) does not have a myeloblast at all, and has a different lineage of hematopoieses than both Goljan and Pathoma!
Can anyone clarify this term for me? And especially in regards to myeloblastic leukemias / disorders? Are myeloproliferative disorders referring to the 'myeloid stem cell' or 'myeloblast' (whatever this is)? Why does AML refer to 'myeloblast' if it has subtypes involving megakaryoblasts (M7)? Shouldn't myeoblast only refer to granulocytes?
Any help is appreciated! I'm dying here.
Last edited: